Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
Browse Other Projects on Experiment
Related Projects
Fancy footwork: How different are the feet of zoo and wild giraffe?
Cooperative training helps zookeepers care for zoo animals. For giraffe, much of this training focuses on...
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
Developing a new tissue preservation method inspired by Tardigrades
There are two routine ways to preserve tissues: formalin-fixed paraffin-embedded preservation (FFPE) and...